tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Financial Statements

Compare
1 Followers

Keymed Biosciences, Inc. Financial Overview

Keymed Biosciences, Inc.'s market cap is currently HK$10.55B. The company's EPS TTM is HK$-2.097; its P/E ratio is ―; Keymed Biosciences, Inc. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 428.12M¥ 354.10M¥ 100.06M¥ 110.27M¥ 0.00
Gross Profit¥ 415.92M¥ 317.22M¥ 97.48M¥ 93.07M¥ 0.00
Operating Income¥ -618.10M¥ -434.80M¥ -295.38M¥ -3.88B¥ -804.70M
EBITDA¥ -574.46M¥ -269.77M¥ -259.25M¥ -3.86B¥ -785.71M
Net Income¥ -515.24M¥ -359.36M¥ -308.12M¥ -3.90B¥ -832.73M
Balance Sheet
Cash & Short-Term Investments¥ 2.16B¥ 2.72B¥ 3.18B¥ 3.52B¥ 354.08M
Total Assets¥ 3.77B¥ 3.88B¥ 3.93B¥ 3.93B¥ 529.95M
Total Debt¥ 753.24M¥ 418.71M¥ 121.97M¥ 39.26M¥ 66.86M
Net Debt¥ 334.82M¥ -432.32M¥ -482.10M¥ -1.48B¥ -132.54M
Total Liabilities¥ 1.29B¥ 896.11M¥ 593.10M¥ 289.07M¥ 1.62B
Stockholders' Equity¥ 2.47B¥ 2.99B¥ 3.34B¥ 3.65B¥ -1.09B
Cash Flow
Free Cash Flow¥ 0.00¥ -686.23M¥ -681.48M¥ -387.50M¥ -139.26M
Operating Cash Flow¥ 0.00¥ -303.62M¥ -401.93M¥ -214.64M¥ -119.36M
Investing Cash Flow¥ 0.00¥ 468.20M¥ -645.59M¥ -2.04B¥ -113.07M
Financing Cash Flow¥ 0.00¥ 72.13M¥ -8.06M¥ 3.64B¥ 7.40M
Currency in CNY

Keymed Biosciences, Inc. Earnings and Revenue History

Keymed Biosciences, Inc. Debt to Assets

Keymed Biosciences, Inc. Cash Flow

Keymed Biosciences, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis